S100A8 and hydrops fetalis: In the present study, we expanded upon previous observations and demonstrated that chronic pharmacological inhibition of S100A8/A9 beneficially prevented TAC-induced pathological hypertrophy and HF in mice, suggesting that blockade of S100A8/A9 represents a new therapeutic option for HF in the clinical setting.